Del Mar Pharmaceuticals' mission is to build shareholder value by rapidly developing and commercializing potential new anti-cancer therapies in orphan indications where patients have failed modern biologic therapy.
To this aim, we have identified well-characterized small-molecules that have previously demonstrated clinical activity in both orphan and large-market cancer indications and are preparing to initiate human clinical trials in collaboration with leading cancer centers in North America.
Click here to view our Corporate Presentation (370kb, PDF)
Our website is currently under construction; in the interim we invite you to click the links above for further information on our company.